On Wednesday, members of the California Senate’s Health Committee approved a bill that seeks to provide clarity surrounding the sale of hemp-derived CBD products.
Currently, the state’s Sherman Food, Drug, and Cosmetic Law prohibits the manufacture, sale, and delivery of adulterated foods, beverages, or cosmetics—and a violation of the law is a misdemeanor.
Assembly Bill 228 would explicitly state that a food, beverage, or cosmetic is “not adulterated by the inclusion of industrial hemp or cannabinoids,” thereby prohibiting restrictions on the sale of food, beverages, and cosmetics that include industrial hemp or its derivatives.
The bill could also affect the state’s cannabis industry. If implemented, entities that are licensed to engage in commercial cannabis sales would be allowed to manufacture, distribute, and sell products that contain industrial hemp.
During the hearing, the bill’s author, Assemblymember Cecilia Aguiar-Curry (D-Winters), noted that “The manufacture and sale of hemp CBD in California is rapidly expanding business, with over one thousand employees and millions of dollars in economic activity.”
“We can already buy these products today at local gyms, coffee shops, wellness stores, and even now at CVS,” she added. “Should the state chose not to clarify that hemp CBD products are legal, these jobs and this business would be lost.”